Literature DB >> 3141684

Lipase deficiencies.

H Greten1, F U Beil.   

Abstract

Two enzymes, lipoprotein lipase and hepatic triglyceride lipase, are involved in the hydrolysis of triglycerides from chylomicrons and very low density lipoprotein (VLDL). Lipoprotein lipase has an absolute requirement for apolipoprotein CII for activity. Three inborn errors of metabolism which give rise to hypertriglyceridaemia have been described. The biochemical and clinical aspects of these disorders, lipoprotein lipase deficiency (familial type I hyperlipoproteinaemia), hepatic triglyceride lipase deficiency and apo-CII deficiency are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3141684     DOI: 10.1007/bf01800568

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  6 in total

1.  A specific apoprotein activator for lipoprotein lipase.

Authors:  J C LaRosa; R I Levy; P Herbert; S E Lux; D S Fredrickson
Journal:  Biochem Biophys Res Commun       Date:  1970-10-09       Impact factor: 3.575

2.  Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase.

Authors:  W C Breckenridge; J A Little; P Alaupovic; C S Wang; A Kuksis; G Kakis; F Lindgren; G Gardiner
Journal:  Atherosclerosis       Date:  1982-11       Impact factor: 5.162

3.  Apolipoprotein CIISt. Michael. Familial apolipoprotein CII deficiency associated with premature vascular disease.

Authors:  P W Connelly; G F Maguire; J A Little
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

4.  Secondary hypertriglyceridaemia in patients with parenchymal liver disease.

Authors:  G Klose; J Windelband; A Weizel; H Greten
Journal:  Eur J Clin Invest       Date:  1977-12       Impact factor: 4.686

5.  Measurement of two plasma triglyceride lipases by an immunochemical method: studies in patients with hypertriglyceridemia.

Authors:  H Greten; R DeGrella; G Klose; W Rascher; J L de Gennes; E Gjone
Journal:  J Lipid Res       Date:  1976-05       Impact factor: 5.922

6.  Hypertriglyceridemia associated with deficiency of apolipoprotein C-II.

Authors:  W C Breckenridge; J A Little; G Steiner; A Chow; M Poapst
Journal:  N Engl J Med       Date:  1978-06-08       Impact factor: 91.245

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.